Article ID Journal Published Year Pages File Type
10929352 Current Opinion in Cell Biology 2009 6 Pages PDF
Abstract
Insulin-producing β cells are lost or insufficient in diabetic patients, presenting the medical challenge for new β cells. Currently, there are three strategies that offer promise. One involves the generation of β cells de novo by directing the differentiation of either embryonic stem cells or induced pluripotent cells to the β cell lineage. The second is based on the conversion of another terminally differentiated cell to β cells in a process called reprogramming. The third approach is to promote the replication of existing β cells either in vivo or in vitro. Significant progress is evident for each strategy, but it remains unclear which approach will ultimately prove successful.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cell Biology
Authors
, ,